原料药行业迎重磅利好!工信部:推动建设原料药集中生产基地

2020-10-02 工业和信息化部 工业和信息化部

近期工信部官网登载了对十三届全国人大三次会议第9883号建议的答复。对权太琦等3名代表提出的关于支持在连云港建立国家级原料药生产基地的建议,进行答复:

近期工信部官网登载了对十三届全国人大三次会议第9883号建议的答复。对权太琦等3名代表提出的关于支持在连云港建立国家级原料药生产基地的建议,进行答复:

原料药处于医药产业链上游,是保障药品供应、满足人民用药需求的基础。2019年12月,工业和信息化部会同国家卫生健康委、生态环境部、国家药监局等部门制定印发了《推动原料药产业绿色发展的指导意见》,进一步推进原料药产业绿色升级,助力医药行业高质量发展。

工业和信息化部将会同相关部门制定原料药生产基地认定标准和工作程序,支持地域空间独立、环境承载能力较强的区域建设原料药集中生产基地。


权太琦等3名代表:

你们提出的关于支持在连云港建立国家级原料药生产基地的建议收悉,现答复如下:

原料药处于医药产业链上游,是保障药品供应、满足人民用药需求的基础。我国是全球最大的化学原料药生产国,原料药生产企业1500余家,在产品种有1600余个,2019年产量达到300余万吨,主营业务收入3800亿元,对促进经济发展、保障人民健康、维护社会稳定发挥了重要作用,在国际竞争中占有一定优势。

为全面贯彻落实《医药工业发展规划指南》,2019年12月,工业和信息化部会同国家卫生健康委、生态环境部、国家药监局等部门制定印发了《推动原料药产业绿色发展的指导意见》,进一步推进原料药产业绿色升级,助力医药行业高质量发展。

一、是调整原料药产业结构

鼓励优化产业资源配置,推进绿色生产技术改造,提高大宗原料药绿色产品比重,加快发展特色原料药和高端定制原料药,严格质量、环保、卫生等标准,依法依规淘汰落后技术和产品,逐步提高原料药产业集中度和规模化生产水平。

二、是优化原料药产业布局

按照生态保护红线、环境质量底线、资源利用上线、生态环境准入清单要求,合理规划产业区域布局,逐步提升原料药主产区绿色发展水平,加快环境敏感区企业升级改造和产业转移,环境空气质量未达标城市应制定更严格的准入标准。

三、是加快技术创新与应用

聚焦产业绿色发展需求,加快推进绿色技术攻关和产业化应用,推广高效提取纯化、绿色酶法合成、微通道反应等绿色工艺,突破一批关键核心绿色技术,培育一批高质量创新型企业,打造一批创新平台、战略联盟、示范基地。

四、是推行绿色生产标准

研究制定推行原料药绿色工厂、绿色园区、绿色管理标准,积极构建资源节约、环境友好、生态文明的绿色生产体系,组织行业协会开展对标评价,发挥优质企业标杆引领作用,推动提升行业绿色发展水平。

五、是推动建设集中生产基地

合理规划原料药产业布局,指导制定行业绿色园区评价标准,支持地方依托现有医药、化工产业园区,通过结构调整、产业升级、优化布局,开展原料药集中生产基地建设,实现公共系统共享、资源综合利用、污染集中治理和产业集聚发展。

下一步,工业和信息化部将会同相关部门制定原料药生产基地认定标准和工作程序,支持地域空间独立、环境承载能力较强的区域建设原料药集中生产基地。

江苏连云港近年来医药产业发展较快,具备一定产业基础和区位优势,基础设施配套较好,我们将进一步指导地方加强原料药产业发展培育,鼓励该地区在具备条件的情况下积极申报国家级原料药生产基地。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2021-09-17 amyloid
  2. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-04 slcumt
  3. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-04 xxxx1054
  5. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-04 ms4000000561534892

    道地药材,严控质量

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1905829, encodeId=3a8819058295e, content=<a href='/topic/show?id=270d4e919d1' target=_blank style='color:#2F92EE;'>#工信部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47919, encryptionId=270d4e919d1, topicName=工信部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Fri Sep 17 07:33:18 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497146, encodeId=d324149e1466f, content=<a href='/topic/show?id=30003e186fa' target=_blank style='color:#2F92EE;'>#原料药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37186, encryptionId=30003e186fa, topicName=原料药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d4d9304903, createdName=slcumt, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549625, encodeId=fcad1549625c5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun Oct 04 14:33:18 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889994, encodeId=8c9c8899948b, content=道地药材,严控质量, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Sun Oct 04 00:42:53 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889808, encodeId=9ee488980811, content=合理规划。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Sat Oct 03 06:20:27 CST 2020, time=2020-10-03, status=1, ipAttribution=)]
    2020-10-03 1488d5e7m58暂无昵称

    合理规划。

    0

相关资讯

过了个年 药价又涨了!

春节过后,很多常用药价格又上调了,药店难寻十元以下感冒咳嗽药。 过了个年,药价又涨了 2月21日,新快报消息称,新快报记者走访多家药店发现,三九感冒灵颗粒、川贝枇杷膏、杏苏止咳药、沐舒坦、腹可安、六味地黄丸、清肺化痰丸等家庭常用药不同程度上涨,有的涨几元、有的涨了几十元。药店难寻十元以下感冒咳嗽药。

为什么要对西药原料药网开一面?

最近大家对于《中华人民共和国药品管理法(修订草案)》中的处罚力度讨论的比较激烈,就好比一场辩题关于“假劣药品处罚下限100万对于西药行业有积极作用还是消极作用”的辩论赛,正反双方都拿出了强有力的辩词来为自己的观点进行辩驳。

缬沙坦价格飙升 创10年新高!

风波后,一原料药价格创10年新高。

新型冠状病毒爆发导致印度的出口限制,引发了人们对全球药品短缺的担忧

随着对COVID-19冠状病毒的爆发,印度决定限制26种活性药物成分(API)和制剂的出口,该决定引起了全球对于药品短缺的担忧。

原料药垄断 大批药品停产

就今年而言,因原料药成本上涨,短缺而导致药品停产的案例,数不胜数原料药垄断,扑尔敏上涨50倍今年,媒体普遍报道扑尔敏原料药短期之内价格快速上涨:已从去年底的 260~280 元 / 公斤,涨至 1.5 万元 / 公斤,足足上涨了 50 倍,高昂的价格导致部分药品停产,引起社会广泛关注。经调查,湖南和河南各有一药企在扑尔敏市场具有市场支配地位,行为违反了《中华人民共和国反垄断法》有关规定。事实上

常用药零售价暴涨背后:原料药供应链被垄断

不少抢救类、止血类、升白细胞类临床常用药,从去年至今已涨价数倍乃至数十倍。同时,市场上药店零售的多种常用药价格也出现大幅上涨。